Date of Award

6-2026

Degree Name

MS in Agriculture - Plant Protection Science

Department/Program

Horticulture and Crop Science

College

College of Agriculture, Food, and Environmental Sciences

Advisor

Shunping Ding

Advisor Department

Horticulture and Crop Science

Advisor College

College of Agriculture, Food, and Environmental Sciences

Abstract

Fusarium wilt, caused by Fusarium oxysporum f. sp. lactucae (FOLac), is a damaging soilborne disease of lettuce (Lactuca sativa L.) for which few effective management options currently exist. This thesis evaluated whether commercially available biological and low-risk fungicide products can suppress Fusarium wilt and deliver measurable biostimulant effects in lettuce, integrating evaluations across greenhouse, small-plot field, and commercial field environments. In the greenhouse, three Fusarium wilt suppression experiments and a separate heat-stress physiology trial were conducted, followed by replicated small-plot field trials under artificial inoculation. Across these experiments, no biological product or low-risk fungicide consistently reduced disease severity area under the disease progress curve relative to inoculated controls, and no treatment significantly affected lettuce physiological responses or biomass under heat stress. In commercial iceberg lettuce fields near Santa Maria, California, three products selected in part for cost-effectiveness were applied through drip chemigation, with disease and canopy development monitored at the plot scale using ground assessments and unmanned aerial vehicle (UAV) multispectral imagery. None of the products provided meaningful disease suppression under commercial conditions; however, UAV-derived vegetation indices (NDVI, NDRE, LAI, and ALN) were strongly correlated with ground-measured disease severity, reliably capturing spatial patterns of Fusarium wilt within fields. Collectively, these results indicate that the biological and low-risk products evaluated did not provide reliable suppression of Fusarium wilt or detectable biostimulant benefits under the conditions tested, while demonstrating that remote sensing can support spatial disease monitoring. These findings emphasize the need for integrated management strategies and for rigorous, field-scale validation of commercial biological products before adoption.

Available for download on Saturday, June 12, 2027

Share

COinS